What's Happening?
Atos has collaborated with the Medicines Manufacturing Innovation Centre to create reusable, technology-agnostic architectural blueprints for pharmaceutical manufacturing. The initiative aims to address industry challenges and promote advancements by applying the open group architecture framework (TOGAF). The project involves continuous collaboration and agile sprints to balance progress with the core team and wider membership, ensuring consensus on blueprinting requirements.
Why It's Important?
The development of reusable architectural blueprints is crucial for the pharmaceutical industry as it seeks to modernize and improve manufacturing processes. By creating technology-agnostic solutions, Atos enables flexibility and adaptability, which can lead to more efficient production methods and cost savings. This approach may serve as a model for other industries looking to innovate without being tied to specific technologies.
AD
What's Next?
Atos plans to continue its agile approach, involving regular reviews and setting new sprint goals to ensure progress aligns with industry needs. The collaboration with the Medicines Manufacturing Innovation Centre and its Digital Membership will likely lead to further advancements in pharmaceutical manufacturing, potentially influencing other sectors to adopt similar strategies for innovation.
